Rapamune and Levaquin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rapamune (sirolimus) and Levaquin (levofloxacin). Common drug interactions include haemoglobin decreased among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Rapamune and Levaquin. It is created by eHealthMe based on reports of 76 people who take the same drugs from the FDA, and is updated regularly.

What is Rapamune?

Rapamune has active ingredients of sirolimus. It is often used in kidney transplant. eHealthMe is studying from 13,848 Rapamune users. Check the latest studies of Rapamune.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.



On Jul, 13, 2026

76 people who take Rapamune and Levaquin together, and have interactions are studied.

Rapamune and Levaquin drug interactions.

What are the common drug interactions of Rapamune and Levaquin, by gender? *:

female:

  1. Haemoglobin decreased
  2. Nausea (feeling of having an urge to vomit)
  3. Renal tubular necrosis (death of kidney tubules)
  4. Vomiting
  5. White blood cell count decreased
  6. Epistaxis (bleed from the nose)
  7. Haemorrhage (bleeding)
  8. Mouth ulceration (mouth ulcers)
  9. Rash
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

male:

  1. Fatigue (feeling of tiredness)
  2. Asthenia (weakness)
  3. General physical health deterioration (weak health status)
  4. Hyperlipidaemia (presence of excess lipids in the blood)
  5. Hypokalaemia (low potassium)
  6. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  7. Osteoporosis (bones weak and more likely to break)
  8. Upper respiratory tract infection
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Vomiting

What are the common drug interactions of Rapamune and Levaquin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anxiety
  2. Depression

20-29:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Post procedural complication
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Abdominal infection
  5. Abdominal pain upper
  6. Acidosis (build-up of carbon dioxide in the blood)
  7. Activated partial thromboplastin time prolonged
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Anxiety
  10. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)

30-39:

  1. Enzyme abnormality
  2. Haemoglobin decreased
  3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  4. Activated partial thromboplastin time prolonged
  5. Alopecia (absence of hair from areas of the body)
  6. Anoxia (low oxygen)
  7. Apnoea (suspension of external breathing)
  8. Asthenia (weakness)
  9. Blood fibrinogen increased
  10. Blood pressure diastolic decreased

40-49:

  1. Cough
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Vomiting
  4. Asthenia (weakness)
  5. Blood pressure increased
  6. Death
  7. Discomfort
  8. Dyspnoea (difficult or laboured respiration)
  9. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  10. Fatigue (feeling of tiredness)

50-59:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Haematuria (presence of blood in urine)
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  4. Osteoporosis (bones weak and more likely to break)
  5. Tremor (trembling or shaking movements in one or more parts of your body)
  6. Upper respiratory tract infection
  7. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  8. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  9. Anaemia (lack of blood)
  10. Anxiety

60+:

  1. Blood urea increased
  2. Blood creatinine increased
  3. Bladder cancer
  4. Blood alkaline phosphatase increased
  5. Blood glucose increased
  6. Blood lactate dehydrogenase increased
  7. Haematocrit decreased
  8. Haemoglobin decreased
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Rash pruritic (redness with itching)

What are the existing conditions these people have? *

  1. High Blood Pressure: 7 people, 9.21%
  2. Pain: 6 people, 7.89%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 7.89%
  4. High Blood Cholesterol: 4 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Rapamune and Levaquin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rapamune and Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rapamune:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rapamune and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levaquin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on sirolimus and levofloxacin (the active ingredients of Rapamune and Levaquin, respectively), and Rapamune and Levaquin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: